New National Survey Highlights High Costs of GLP-1 Medications and Mixed Public Views on AI in Diabetes Care
· GlobeWire Daily Editorial Desk · Source: www.prnewswire.com

Image: American Diabetes Association · Photo source · Resized and letterboxed to 16:9; no AI generation
A national survey conducted by Ipsos on behalf of the American Diabetes Association (ADA) indicates that more than three in five Americans report that someone close to them has been diagnosed with diabetes or prediabetes. Released during American Diabetes Month, the poll outlines public perceptions regarding treatment costs, research funding, and artificial intelligence in healthcare.
Key Survey Findings
- Pervasive Impact: Over 63% of respondents stated that at least one close family member, friend, or coworker has been diagnosed with diabetes or prediabetes.
- Cost Barriers: A majority of respondents (56%) noted that the cost of GLP-1-based medications poses a barrier for individuals who could benefit from them, with 26% categorizing it as a very significant barrier.
- Research Investment: Over 50% of surveyed adults believe the government invests too little in diabetes research, compared to only 3% who feel investment is excessive.
- Optimism for Type 1 Progress: Half of Americans surveyed expressed optimism that a major advance in type 1 diabetes treatment is likely within the next decade.
- Artificial Intelligence Divide: Public opinion regarding AI is split, with 32% reporting comfort in receiving real-time recommendations from AI tools for diabetes management, while 37% reported discomfort. Generational differences were noted, as Baby Boomers showed the highest discomfort at 44% compared to 30% among Millennials.
ADA Initiatives and Practical Implications
To address the gaps identified in the survey, the ADA highlights several ongoing programs and advocacy efforts:
- Cost and Access: Advocating for affordable insulin, obesity treatments, and healthcare access.
- Research Funding: Pointing to approximately $1 billion funded in diabetes research since 1952 while opposing federal funding cuts.
- Primary Care and Community Support: Equipping clinicians in primary care settings—where 90% of diabetes patients are treated—alongside community hubs offering education, screenings, and food distribution.
- Family and Youth Support: Operating ADA Camp for children with diabetes and providing resources such as the Diabetes Food Hub.
Verification and Methodology
The survey was conducted online by Ipsos between October 29 and October 30, 2026, using a nationally representative sample of 1,005 U.S. adults aged 18 and older. The results carry a credibility interval of plus or minus 3.8 percentage points. Readers can verify official statements, read full methodological details, or share personal stories by visiting the American Diabetes Association's official website at diabetes.org.
AI-assisted reporting; source claims are attributed and have not been independently verified.



